WHO raises alarm as antibiotic resistance threatens global health gains
The report links this growing resistance to the misuse of antibiotics, poor infection control, and weak surveillance systems, particularly in developing regions.
The World Health Organisation (WHO) has sounded the alarm over the accelerating threat of antibiotic resistance, warning that lifesaving drugs are losing their effectiveness at an alarming rate.
In its Global Antimicrobial Resistance Surveillance Report 2025, WHO revealed that nearly one in six bacterial infections recorded globally in 2023 failed to respond to standard antibiotic treatment.
More To Read
- Scientists discover brain cells linked to depression, offering hope for better treatments
- Inside El Fasher: A city under siege as hospitals and civilians face relentless attacks
- WHO says rebuilding Gaza’s shattered health system critical to a lasting peace
- WHO warns of alarming teen vaping surge as 15 million adolescents now using e-cigarettes
- Growing health crisis among Kenya’s elderly: Costs, care and insurance coverage
- Gaza health system overwhelmed as WHO reports 42,000 people have life-changing injuries
The report links this growing resistance to the misuse of antibiotics, poor infection control, and weak surveillance systems, particularly in developing regions.
Data gathered from 104 countries through the WHO’s Global Antimicrobial Resistance and Use Surveillance System (GLASS) showed that resistance has increased in more than 40 per cent of the monitored pathogen–antibiotic combinations since 2018.
WHO said resistance was most widespread in the South-East Asia and Eastern Mediterranean regions, where one in three infections resisted treatment.
In Africa, one in five bacterial infections was resistant, with some countries reporting resistance rates exceeding 70 per cent due to limited diagnostic services and poor access to quality medicines.
“Drug resistance is spreading faster than our ability to respond, and that puts every person at risk,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus.
He emphasised that countries must not only invest in surveillance and research but also ensure rational antibiotic use and access to vaccines and reliable diagnostics.
The report cites E. coli and Klebsiella pneumoniae as among the most resistant bacteria, with more than half of the samples tested showing no response to third-generation cephalosporins, the frontline drugs used for severe infections.
Increasing resistance to carbapenems and fluoroquinolones has left doctors with fewer treatment options, especially in low- and middle-income nations where newer drugs remain scarce or too costly.
Despite these challenges, WHO noted steady progress in surveillance efforts, with the number of participating countries in GLASS more than quadrupling since 2016.
However, nearly half of them still lack robust systems to produce accurate, reliable data.
Dr Tedros urged governments and health agencies to accelerate efforts to combat antimicrobial resistance through the “One Health” approach, which integrates human, animal, and environmental health interventions.
“Our collective future depends on coordinated action,” he said, stressing the urgency of global collaboration, responsible antibiotic use, and investment in next-generation treatments to protect future generations from untreatable infections.
Top Stories Today
